Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Rogaratinib |
| Trade Name | |
| Synonyms | BAY 1163877|BAY-1163877|BAY1163877 |
| Drug Descriptions |
Rogaratinib (BAY 1163877) is a small molecule pan-FGFR inhibitor, which reduces downstream signaling, potentially resulting in decreased tumor cell proliferation (PMID: 27429073, PMID: 29451369, PMID: 30807645, PMID: 31405822). |
| DrugClasses | FGFR Inhibitor (Pan) 26 |
| CAS Registry Number | 1443530-05-9 |
| NCIT ID | C112205 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Rogaratinib | Atezolizumab Rogaratinib | 1 | 1 |
| Carboplatin + Paclitaxel + Rogaratinib | Carboplatin Paclitaxel Rogaratinib | 1 | 0 |
| Copanlisib + Rogaratinib | Copanlisib Rogaratinib | 0 | 1 |
| Crizotinib + Rogaratinib | Crizotinib Rogaratinib | 0 | 0 |
| Docetaxel + Rogaratinib | Docetaxel Rogaratinib | 2 | 0 |
| Fulvestrant + Palbociclib + Rogaratinib | Fulvestrant Palbociclib Rogaratinib | 0 | 1 |
| Rogaratinib | Rogaratinib | 23 | 5 |